咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Genetics and genomics of prost... 收藏

Genetics and genomics of prostate cancer

Genetics and genomics of prostate cancer

作     者:Michael Dean Hong LOU 

作者机构:Cancer and Inflammation Program National Cancer Institute National Institutes of Health Frederick MD 21702 USA Basic Science Program SAIC-Frederick Nationa Cancer Institute National Institutes of Health Frederick MD 21702 USA 

出 版 物:《Asian Journal of Andrology》 (亚洲男性学杂志(英文版))

年 卷 期:2013年第15卷第3期

页      面:309-313页

核心收录:

学科分类:0710[理学-生物学] 1002[医学-临床医学] 07[理学] 071007[理学-遗传学] 

基  金:supported by the Intramural Research Program of the NIH  the National Cancer Institute Center for Cancer Research 

主  题:androgen receptor cancer progression chromatin remodeling metastasis prostate cancer (PCa) risk factor somaticmutation tumor heterogeneity 

摘      要:Prostate cancer (PCa) is one of the most common malignancies in the world with over 890 000 cases and over 258 000 deaths worldwide each year. Nearly all mortalities from PCa are due to metastatic disease, typically through tumors that evolve to be hormone-refractory or castrate-resistant. Despite intensive epidemiological study, there are few known environmental risk factors, and age and family history are the major determinants. However, there is extreme heterogeneity in PCa incidence worldwide, suggesting that major determining factors have not been described. Genome-wide association studies have been performed and a considerable number of significant, but low-risk loci have been identified. In addition, several groups have analyzed PCa by determination of genomic copy number, fusion gene generation and targeted resequencing of candidate genes, as well as exome and whole genome sequencing. These initial studies have examined both primary and metastatic tumors as well as murine xenografts and identified somatic alterations in TP53and other potential driver genes, and the disturbance of androgen response and cell cycle pathways. It is hoped that continued characterization of risk factors as well as gene mutation and misregulation in tumors will aid in understanding, diagnosing and better treating PCa.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分